
The tech giant came up with a device able to draw blood quick and painless, no needles involved.
We are all aware of Google’s achievements in the area of smart devices, capable of making our lives much easier. But Google wants to step up a bit and extend its grasps to other niches. Google patents needle-free blood draw device, aimed to help people who require frequent blood tests.
The device, in the form of a small cartouche, is designed to fit any devices that can be attached on the wrist. Furthermore, he blood draw apparatus will come in handy to those with elevated blood sugar that require frequent testing. The apparatus features a piston-like device that is capable of shooting gas into a hollow cylinder. The cylinder contains a special kind of micro-particle which is capable of tearing through the skin. This particle enters the blood stream and then draws a small blood sample. After that, the particle retracts inside a small barrel, which will be placed directly onto the skin.
Given its size and functionality, the device could be easily incorporated into any smart device, such as a Smartwatch. According to initial predictions, the device is only capable of drawing small amounts of blood in order to conduct a simple test like checking the level of blood glucose.
Unfortunately, no information regarding the device itself were announced. Google did not wish to comment on a timeframe or a specific launch date. They just said the concept is purely a patent and that in no way is Google obliged to deliver the device on the market.
Google also commented that the idea of a pain-free and needle-free device is not something entirely new to them. Back in 2014, Google experimented with a pair of contact lenses which were able to measures a patient’s level of blood sugar by sampling his tears.
Google patents needle-free blood draw device as per their desire of creating smart devices capable of doing more for its users. We already know about Google’s innovation in the area of applications capable of measuring other physiological parameters such as heart rate. But a device of this magnitude could come in handy for those who require frequent testing. Furthermore, although the products look rather bulky and unrefined, through additional tweaking, the Google think-tanks will be able to extend the end product’s functionality. It may be that the wearable device can be engineered to measure more than our blood sugar levels.
We eagerly await to see if Google will live up to its promise, taking their idea from theory to practice.
Image source:www.pharmafile.com